WELLESLEY HILLS, Mass., Sept. 22 /PRNewswire/ -- Joseph F. Finn, Jr.,
C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for
the benefit of creditors, announced today that all oral drug delivery
intellectual property will be sold at a sealed bid auction on October 10,
The three presentations were:
1. BIOROD -- Bioadhesive Based Oral Delivery System
2. Biological Factors Affecting the Bioadhesion Performance of Spheromer III
3. Pharmacokinetics Evaluation of Topiramate Immediate Release Tablets and Topiramate Extended Release Capsules in Healthy Volunteers (BIOGIT Based)
These proprietary technologies (BIOROD, BIOGIT, and SPHEROMER) facilitate targeted drug delivery throughout the gastrointestinal tract and address clinical unmet needs.
Persons interested in bidding must sign a Confidentiality Agreement ("CA") obtained from Finn's office -- email@example.com or 781-237-8840. They will then receive a bid package and access to the Spherics electronic data room.
Spherics has built a strong intellectual property position around its drug delivery technologies and products. The Company has a broad range of issued US and international patents that they have applied to their four central nervous system products. These patents cover polyanhydride-based bioadhesive polymers and nanotechnology (PIN(TM)). In addition to these issued patents, Spherics has filed numerous applications covering compositions of matters of its proprietary polymers (SPHEROMERS(TM)), novel oral delivery systems (including BIOGIT(TM), BIOROD(TM) and PIN(TM)), manufacturing methods, methods of use, formulations and product compositions.
About Joseph F. Finn, Jr., C.P.A.
Joseph F. Finn, Jr., is the founding partner of the firm, Finn, Warnke
& Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts.
He works primarily in t
|SOURCE Spherics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved